As part of one of the nation’s leading academic medical centers, UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center offers a broad spectrum of clinical trials aimed at improving the outcomes of patients with leukemia. Patients should talk to their doctor about joining a clinical trial.
Some of our current clinical trials are:
- Beat AML
- A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients with AML or MDS
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
See all current clinical trials.
Groundbreaking Initiative to Beat Aggressive Form of Leukemia
Only 27 percent of patients with acute myeloid leukemia live at least five years after the cancer is found. UT Southwestern is trying to change that. We have been selected as the only site in Texas for a national Cancer Moonshot clinical trial to find individually tailored approaches to better treat acute myeloid leukemia. This trial is known as the Beat AML trial.
